Nonendocytic Delivery of Functional Engineered Nanoparticles into the Cytoplasm of Live Cells Using a Novel, High-Throughput Microfluidic Device

# Nonendocytic Delivery of Functional Engineered Nanoparticles into the Cytoplasm of Live Cells Using a Novel, High-Throughput Microfluidic Device This page is a text version of a Portal Biotechnologies publication. The bibliographic record is labeled in the text so it can be read without the surrounding website. ## Bibliographic record - Title: Nonendocytic Delivery of Functional Engineered Nanoparticles into the Cytoplasm of Live Cells Using a Novel, High-Throughput Microfluidic Device - Document type: Publication - Year: 2012 - Outlet: NANO LETTERS - Cells: Cancer Cell Lines - Cargos: nanoparticle, Polymers - Page URL: https://portal.bio/publications/2012-nonendocytic-delivery-of-functional-engineered-nanoparticles-into-the-cytoplasm-of-li--ajkHaxEAACkAc-GX - Markdown URL: https://portal.bio/publications/2012-nonendocytic-delivery-of-functional-engineered-nanoparticles-into-the-cytoplasm-of-li--ajkHaxEAACkAc-GX.md - External publication: https://pubs.acs.org/doi/abs/10.1021/nl303421h ## Summary Jungmin Lee, Armon Sharei, Woo Young Sim, Andrea Adamo, Robert Langer, Klavs F. Jensen, and Moungi G. Bawendi ## Publication text Portal does not host the full text of this publication. The summary on this page and the external publication are the available sources. ## Provenance Some publications reference SQZ Biotechnologies, a company Dr. Armon Sharei and colleagues previously founded. Portal is the next generation company leveraging Dr. Sharei's platform technology.